Rosacea is spoken about as one disease, treated as one word, and that single word is why so many patients feel their treatment missed. The condition arrives in subtypes, and each answers to different tools. GLOW Dermatology in Cheongdam draws the map.

The four classic presentations
Erythemato-telangiectatic rosacea leads with flushing and persistent central redness plus visible vessels. Papulopustular rosacea adds acne-like bumps and pustules on the red base, the subtype most mistaken for adult acne. Phymatous rosacea thickens skin, most famously at the nose, and rhinophyma is its late chapter. Ocular rosacea irritates eyes and lids, often unrecognized for years. Most real patients blend two presentations, which is exactly why the exam matters more than the label.
Different subtypes, different tools
Vessel-led disease answers to vascular lasers such as V-beam across a short series. Bump-led disease answers first to medication, topical and sometimes oral, with lasers joining after inflammation quiets. Thickening responds to resurfacing approaches once disease is controlled, and eye involvement belongs with ophthalmic care in parallel. Trigger management and barrier repair underlie every subtype, but they are the floor, not the treatment.

Why naming your subtype changes outcomes
Lasering pustular disease disappoints; medicating pure vessels disappoints equally. The patients who improve fastest are those whose plan names what they have.
GLOW Dermatology in Cheongdam subtypes rosacea at examination before prescribing lasers, medication or both, consulting international patients. If treatment has failed you before, ask which subtype was being treated; the answer often explains the history.